Remdesivir — supply status, manufacturers & alternatives

Remdesivir

—

🇦🇺 AUST R 338419 · Gilead Sciences Pty Ltd

In supply · Australia

Veklury

In supply · 🇦🇺 Australia · short in🇺🇸 US

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Therapeutic category
Active ingredient (INN)	Remdesivir
Brand names	Veklury

Controlled substance	No

Marketing-authorisation holders	Gilead Sciences Pty Ltd

Registrations on file	1

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

Global API supply base 🇺🇸 FDA Drug Master Files · active Type II

2 API manufacturers

Manufacturers with an active Type II Drug Master File — i.e. cleared to supply this active ingredient into the US market. A proxy for how concentrated the global manufacturing base is.

High concentration risk

Msn Life Sciences Private LTDHonour Lab LTD

Manufacturing countries: India · Source: FDA List of Drug Master Files

Recalls official enforcement reports

🇺🇸

VEKLURY

Gilead Sciences, Inc. · Sept 2024

Class Idetails ↗

🇺🇸

VEKLURY

Gilead Sciences, Inc. · Dec 2021

Class Idetails ↗

🇨🇦

Remdesivir authorized with conditions for the treatment of patients in Canada with severe COVID

Communications and Public Affairs Branch · July 2020

Class ?details ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders1 registration · 1 MA holder

Product	Strength	Form	Market	MA holder	Status
VEKLURY remdesivir	100 mg	—	🇦🇺 AU	Gilead Sciences Pty Ltd	Active

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.